Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing.
Köstek O, Demirel A, Hacıoğlu MB, Tastekin D, Karabulut S, Gündogdu A, Sever N, Ayhan M, Çelebi A, Majidova N, Yaşar A, Ağyol Y, Erel P, Kocaaslan E, Güren AK, Arıkan R, Isık S, Ercelep O, Goksu SS, Alandag C, Bilgetekin İ, Caner B, Sahin AB, Gulmez A, Akagunduz B, Kose F, Kaplan MA, Dogan E, Sakalar T, Guven DC, Gurbuz M, Ergun Y, Karaagac M, Turker S, Ozkul O, Yıldız B, Sahin S, Demiray AG, Sari M, Erdogan B, Hacıbekiroglu İ, Çakmak Öksüzoğlu ÖB, Kilickap S, Bilici A, Bayoglu İV, Topaloglu S, Cicin İ. Köstek O, et al. Among authors: guren ak. J Chemother. 2024 Nov;36(7):613-621. doi: 10.1080/1120009X.2024.2305066. Epub 2024 Jan 23. J Chemother. 2024. PMID: 38263804
Sorafenib vs chemotherapy in the treatment of locally advanced or metastatic, radioactive iodine-refractory differentiated thyroid cancer: real-world data from Turkey.
Majidova N, Aghamaliyeva S, Guliyev M, Dinc G, Akyıldız A, Ozcan E, Akdağ Kahvecıoglu F, Çağrı Yıldırım H, Sever N, Guren AK, Kocaaslan E, Erel P, Agyol Y, Celebi A, Arıkan R, Isık S, Bayoglu IV, Demirci NS, Dizdar Ö, Hacıbekiroğlu I, Kostek O, Sarı M. Majidova N, et al. Among authors: guren ak. J Chemother. 2024 Nov 26:1-6. doi: 10.1080/1120009X.2024.2430845. Online ahead of print. J Chemother. 2024. PMID: 39588941
Total Neoadjuvant Therapy Versus Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer: A Multi-Institutional Real-World Study.
Şenocak Taşçı E, Mutlu AU, Saylık O, Ölmez ÖF, Bilici A, Sünger E, Sütçüoğlu O, Çakmak Öksüzoğlu ÖB, Özdemir N, Akdoğan O, Bayoğlu İV, Majidova N, Güren AK, Özen Engin E, Hacıbekiroğlu İ, Er Ö, Dane F, Bozkurt M, Turan Canbaz E, Erdamar S, Aytaç E, Özer L, Yıldız İ. Şenocak Taşçı E, et al. Among authors: guren ak. Cancers (Basel). 2024 Sep 21;16(18):3213. doi: 10.3390/cancers16183213. Cancers (Basel). 2024. PMID: 39335184 Free PMC article.
Which factors help to determine the long-term response to first-line tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma: A Turkish multi-centre study.
Majidova N, Seyyar M, Bayraktar DI, Dinç G, İsgandarov E, Huseynov J, Yaşar A, Çelebi A, Sever N, Kocaaslan E, Erel P, Ağyol Y, Güren AK, Arıkan R, Işık S, Ercelep Ö, Demirağ G, Kefeli U, Köstek O, Bayoğlu İV, Sarı M. Majidova N, et al. Among authors: guren ak. Biomol Biomed. 2024 Oct 17;24(6):1776-1784. doi: 10.17305/bb.2024.10512. Biomol Biomed. 2024. PMID: 38920621 Free PMC article.
Clinicopathologic Features and Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma: Real-World Experience.
Majidova N, Sarı M, Kahvecioglu FA, Ozcan E, Akdag MO, Dogan A, Yıldırım S, Sonusen SD, Yunusov E, Yasar A, Celebi A, Sever N, Kocaaslan E, Erel P, Agyol Y, Guren AK, Arıkan R, Isık S, Balvan O, Geredelı C, Uygun K, Hacibekiroglu I, Kostek O, Bayoglu IV. Majidova N, et al. Among authors: guren ak. Oncol Res Treat. 2024;47(7-8):360-367. doi: 10.1159/000537988. Epub 2024 Apr 2. Oncol Res Treat. 2024. PMID: 38565096 Free article.